Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 672,750 | 675,195 | 661,055 | 585,000 | 458,157 |
| Cost of Goods | 311,756 | 311,711 | 304,533 | 257,000 | 225,841 |
| Gross Profit | 360,994 | 363,485 | 356,522 | 328,000 | 232,316 |
| Operating Expenses | 255,408 | 252,279 | 234,313 | 220,000 | 121,411 |
| Operating Income | 107,342 | 111,916 | 122,742 | 107,000 | 111,746 |
| Interest Expense | 4,023 | 2,575 | 3,402 | 3,000 | 2,540 |
| Other Income | -13,642 | -70,401 | -2,957 | 12,000 | -27,671 |
| Pre-tax Income | 89,677 | 38,940 | 116,384 | 116,000 | 81,535 |
| Income Tax | 35,299 | 36,228 | 13,473 | 40,000 | -5,658 |
| Net Income Continuous | 54,378 | 2,712 | 102,911 | 76,000 | 87,193 |
| Net Income | $53,378 | $2,712 | $102,911 | $77,000 | $88,193 |
| EPS Basic Total Ops | 0.06 | 0.00 | 0.12 | 0.09 | 0.11 |
| EPS Basic Continuous Ops | 0.07 | 0.00 | 0.12 | 0.09 | 0.11 |
| EPS Diluted Total Ops | 0.09 | 0.00 | 0.12 | 0.09 | 0.11 |
| EPS Diluted Continuous Ops | 0.07 | 0.00 | 0.12 | 0.09 | 0.10 |
| EBITDA(a) | $149,342 | $156,916 | $167,742 | $150,000 | $143,746 |